Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characteristics of harmful sexual behaviour in autistic adolescent males as compared to controls.

Psychiatry, psychology, and law : an interdisciplinary journal of the Australian and New Zealand Association of Psychiatry, Psychology and Law·2025
Same author

Pathomic immune biomarkers define recurrence risk in early-stage melanoma.

The oncologist·2025
Same author

Active Forms of Chemerin Are Elevated in Human and Mouse Ovarian Carcinoma.

Biomedicines·2025
Same author

Simultaneous Cases of Carfilzomib-Induced Thrombotic Microangiopathy in 2 Patients With Multiple Myeloma.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2022
Same author

Smartphone-based mobility metrics capture daily social motivation and behavior in schizophrenia.

Schizophrenia research·2022
Same author

Capturing Structural Variants of Herpes Simplex Virus Genome in Full Length by Oxford Nanopore Sequencing.

Microbiology spectrum·2022

Related Experiment Video

Updated: May 31, 2026

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
03:50

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease

Published on: August 18, 2023

Chronic constipation: an evidence-based review.

Lawrence Leung1, Taylor Riutta, Jyoti Kotecha

  • 1Department of Family Medicine, Queen's University, Kingston, Ontario, Canada. leungl@queensu.ca

Journal of the American Board of Family Medicine : JABFM
|July 9, 2011
PubMed
Summary
This summary is machine-generated.

Chronic constipation management requires understanding its cause, whether slow colonic transit or pelvic floor dysfunction. Evidence-based treatments, including biofeedback and novel medications, offer effective relief tailored to the specific etiology.

Related Experiment Videos

Last Updated: May 31, 2026

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
03:50

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease

Published on: August 18, 2023

Area of Science:

  • Gastroenterology
  • Family Medicine
  • Clinical Practice

Background:

  • Chronic constipation is a prevalent condition, particularly in the elderly and women.
  • Lack of a universal definition leads to varied physician and patient interpretations.
  • Etiologies include slow colonic transit and pelvic floor dysfunction, necessitating distinct treatment approaches.

Purpose of the Study:

  • To synthesize current knowledge on chronic constipation.
  • To review evidence-based treatment strategies.
  • To provide updated guidance for clinical practice.

Main Methods:

  • Systematic literature review of PubMed, EMBASE, and Cochrane Database.
  • Analysis of evidence levels using the Strength of Recommendation taxonomy.
  • Synthesis of findings to inform treatment recommendations.

Main Results:

  • Standard advice (fiber, fluids, exercise) benefits only select patients.
  • Biofeedback is effective for pelvic floor dysfunction-related constipation.
  • Pharmacological agents and novel compounds offer diverse treatment options.
  • Evidence does not support a link between senna abuse and colon cancer.

Conclusions:

  • Management of chronic constipation must be individualized based on etiology.
  • Treatment decisions should be guided by the best available evidence.